Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Erivedge vismodegib regulatory update

The European Commission conditionally approved an MAA from Roche for Erivedge vismodegib to treat adults with symptomatic metastatic or locally advanced basal cell carcinoma

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE